Ginger Extract–Loaded Transethosomes for Effective Transdermal Permeation and Anti-Inflammation in Rat Model
DOI: https://doi.org/10.2147/IJN.S400604
IF: 7.033
2023-03-15
International Journal of Nanomedicine
Abstract:Abeer S Hassan, 1 Amal Hofni, 2 Mohammed AS Abourehab, 3 Iman AM Abdel-Rahman 4 1 Department of Pharmaceutics, Faculty of Pharmacy, South Valley University, Qena, Egypt; 2 Department of Pharmacology and Toxicology, Faculty of Pharmacy, South Valley University, Qena, Egypt; 3 Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Minia University, Minia, Egypt; 4 Department of Pharmacognosy, Faculty of Pharmacy, South Valley University, Qena, Egypt Correspondence: Abeer S Hassan, Department of Pharmaceutics, Faculty of Pharmacy, South Valley University, Qena, Egypt, Tel +201012060262, Email Introduction: Ginger extract (GE) has sparked great interest due to its numerous biological benefits. However, it suffers from limited skin permeability, which challenges its transdermal application. The target of the current work was to develop transethosomes as a potential nanovehicle to achieve enhanced transdermal delivery of GE through the skin. Methods: GE–loaded transethosomes were prepared by cold injection using different edge activators. The fabricated nanovesicles were evaluated for particle size, ζ-potential, encapsulation efficiency, and in vitro drug release. The selected formulation was then laden into the hydrogel system and evaluated for ex vivo permeability and in vivo anti-inflammatory activity in a carrageenan-induced rat-paw edema model. Results: The selected formulation comprised of sodium deoxycholate exhibited particle size of 188.3± 7.66 nm, ζ-potential of − 38.6± 0.08 mV, and encapsulation efficiency of 91.0%± 0.24%. The developed transethosomal hydrogel containing hydroxypropyl methylcellulose was homogeneous, pseudoplastic, and demonstrated sustained drug release. Furthermore, it exhibited improved flux (12.61± 0.45 μg.cm 2 /second), apparent skin permeability (2.43± 0.008× 10 − 6 cm/second), and skin deposition compared to free GE hydrogel. In vivo testing and histopathological examination revealed that the GE transethosomal hydrogel exhibited significant inhibition of edema swelling compared to free GE hydrogel and ketoprofen gel. The animals that were treated with ginger transethosome hydrogel showed a significant decrement in reactive oxygen species and prostaglandin E 2 compared to untreated animals. Conclusion: Transethosomes might be a promising new vehicle for GE for effective skin permeation and anti-inflammation. To the best of our knowledge, this work is the first utilization of transethosomes laden into hydrogel as a novel transdermal delivery system of GE. Graphical Keywords: nanovesicles, transethosomes, ginger, ex vivo permeation, transdermal delivery, inflammation Several pathological disorders, such as rheumatoid arthritis and osteoarthritis, are triggered by inflammation. Active drug products that inhibit inflammation are potentially used to prevent the development of these disorders. Though different anti-inflammatory agents, either steroidal anti-inflammatory drugs (SAIDs) or non-SAIDs (NSAIDs), are utilized for inflammation management, they show several adverse effects. Using SAIDs may cause obesity and sodium retention, which result in serious health hazardous, including liver toxicity and gastrointestinal ulcers, the most common NSAID side effects. 1 Clinical investigations have found local adverse effects in 6.3% of participants following local administration of NSAIDs, such as irritation at the application site and itching. Several studies have reported on new drug products that improve the anti-inflammatory performance of drugs and limit their undesirable effects. Natural plants are characterized by several bioactive phytochemicals possessing anti-inflammatory activity. 2 Employing natural medicinal plants may have some advantages compared to conventional pharmaceuticals, such as a better safety profile and lower price. However, limited bioavailability, tissue permeability, and low levels of phenolic moieties in plant extracts are the major challenges of using these medicinal plant products. 3 These shortcomings necessitate the production of reliable delivery nanovehicles to improve their permeability and boost therapeutic performance. Transdermal delivery systems using nanocarriers can offer sufficient quantities of active ingredients for long periods and avoid their extensive liver metabolism. 4 Moreover, transdermal delivery of nanocarriers can be used to enhance local dermal effects and permeation through the skin for systemic performance. 5 Recently, vesicular nanocarriers have received great interest in applications of topical and transdermal drug delivery becaus -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology